Authors:
BARKLEY JV
DHANDA A
KNUTSEN LJS
NIELSEN MB
ROBERTS SM
VARLEY DR
Citation: Jv. Barkley et al., STEREOSELECTIVE CONVERSION OF 2',3'-DIDEOXYDIDEHYDRO CARBOCYCLIC NUCLEOSIDES INTO 2'-DEOXY CARBOCYCLIC NUCLEOSIDES, Chemical communications, (10), 1998, pp. 1117-1118
Authors:
MOGENSEN JP
ROBERTS SM
BOWLER AN
THOMSEN C
KNUTSEN LJS
Citation: Jp. Mogensen et al., THE SYNTHESIS OF NEW ADENOSINE A(3) SELECTIVE LIGANDS CONTAINING BIOISOSTERIC ISOXAZOLES, Bioorganic & medicinal chemistry letters, 8(13), 1998, pp. 1767-1770
Citation: Mj. Sheardown et Ljs. Knutsen, UNEXPECTED NEUROPROTECTION OBSERVED WITH THE ADENOSINE A(2A) RECEPTORAGONIST CGS-21680 (VOL 39, PG 108, 1996), Drug development research, 40(1), 1997, pp. 99-99
Citation: Js. Valsborg et al., C-14 LABELING OF A NOVEL ANTIISCHEMIC ADENOSINE A(1) AGONIST AT PURINE C-8, Journal of labelled compounds & radiopharmaceuticals, 38(5), 1996, pp. 497-507
Citation: Mj. Sheardown et Ljs. Knutsen, UNEXPECTED NEUROPROTECTION OBSERVED WITH THE ADENOSINE A(2A) RECEPTORAGONIST CGS-21680, Drug development research, 39(1), 1996, pp. 108-114
Authors:
HIBBS DE
HURSTHOUSE MB
KNUTSEN LJS
MALIK KMA
OLIVO HF
ROBERTS SM
VARLEY DR
XIONG H
Citation: De. Hibbs et al., PREPARATION AND DETERMINATION OF THE ABSOLUTE-CONFIGURATION OF OPTICALLY-ACTIVE 9-HYDROXY-7-OXABICYCLO[4.3.0]NON-4-EN-8-ONES, Acta chemica Scandinavica, 49(2), 1995, pp. 122-127
Citation: Js. Valsborg et al., SYNTHESIS OF [8-C-14]-2,6-DICHLORO-9H-PURINE, A RADIOLABELED PRECURSOR FOR C-14 NUCLEOSIDES, Journal of labelled compounds & radiopharmaceuticals, 36(5), 1995, pp. 457-464
Citation: Ljs. Knutsen et al., THE SYNTHESIS AND BIOCHEMICAL EVALUATION OF NEW A(1) SELECTIVE ADENOSINE RECEPTOR AGONISTS CONTAINING 6-HYDRAZINOPURINE MOIETIES, Bioorganic & medicinal chemistry letters, 3(12), 1993, pp. 2661-2666
Authors:
ANDERSEN KE
BRAESTRUP C
GRONWALD FC
JORGENSEN AS
NIELSEN EB
SONNEWALD U
SORENSEN PO
SUZDAK PD
KNUTSEN LJS
Citation: Ke. Andersen et al., THE SYNTHESIS OF NOVEL GABA UPTAKE INHIBITORS .1. ELUCIDATION OF THE STRUCTURE-ACTIVITY STUDIES LEADING TO THE CHOICE OF ETHYL-2-THIENYL)-3-BUTENYL]-3-PIPERIDINECARBOXYLIC ACID (TIAGABINE) AS AN ANTICONVULSANTDRUG CANDIDATE, Journal of medicinal chemistry, 36(12), 1993, pp. 1716-1725
Citation: H. Klitgaard et al., CONTRASTING EFFECTS OF ADENOSINE-A1 AND ADENOSINE-A2 RECEPTOR LIGANDSIN DIFFERENT CHEMOCONVULSIVE RODENT MODELS, European journal of pharmacology, 242(3), 1993, pp. 221-228